#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ependymoma Thymic carcinoma Paraganglion neoplasm Autoinflammation with infantile enterocolitis Hypochondroplasia Fungal infection Non-Hodgkin's lymphoma unspecified histology indolent Neuroendocrine tumour Myasthenia gravis Corneal neovascularisation Autoimmune myositis Amyotrophic lateral sclerosis Multiple system atrophy Epilepsy Short-bowel syndrome More trials…

    Learn about Rare Diseases

    Systemic mastocytosis – Diagnostics Pelizaeus-Merzbacher disease – Basic Information Systemic sclerosis pulmonary – Life with Disease Chondrosarcoma – Life with Disease Bronchiolitis obliterans syndrome – Life with Disease Lysosomal storage disorder – Basic Information Cystic fibrosis – Treatment Congenital nephrogenic diabetes insipidus – Life with Disease Usher’s syndrome – Trials in Disease Mast cell activation syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Follitropin Delta Ambrisentan Efpegerglucagon Gemtuzumab Ozogamicin Metoprolol Tartrate Lumasiran BMS-986365 Specific Nucleic Acid Sna-Xfsc Ivosidenib Loratadine Sunitinib Phenylephrine Hydrochloride 11902A Umeclidinium Bromide Istaroxime Reparixin Odm-212 Litifilimab Etavopivat GSKVX000000030918 More therapies…

    Learn about Your Condition

    Aplastic anaemia Psoriasis Neurofibrosarcoma Interstitial lung disease Hyperglycaemia Pulmonary hypertension Albright's disease Brain neoplasm malignant Chronic kidney disease Diabetic retinal oedema Myelodysplastic syndrome Uterine leiomyosarcoma Meniscus injury Hyperplasia adrenal Myasthenia gravis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Amiloride tablets for prevention of migraine with aura attacks

    Recruiting

    4 1 1
    Investigated Diseases:
    • Migraine with aura
    Investigated Drugs:
    • Amiloride Hydrochloride Dihydrate
    France

  • Study on Semaglutide for Weight Control in Patients with Schizophrenia and High BMI Using Antipsychotics

    Recruiting

    3 1 1
    Investigated Diseases:
    • Metabolic disorder
    Investigated Drugs:
    • Semaglutide
    Norway

  • Study on Shortened Antibiotic Treatment for Infectious Endocarditis Using Vancomycin, Meropenem, and Ceftriaxone for Patients with Left-Sided Heart Infection

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endocarditis
    Investigated Drugs:
    • Ampicillin
    • Benzylpenicillin Sodium
    • Cloxacillin Sodium
    Sweden

  • Study on Buccalin for Preventing Recurrent Lower Respiratory Infections in Adults

    Recruiting

    3 1 1
    Investigated Drugs:
    • Haemophilus Influenzae
    • Staphylococcus Aureus
    • Streptococcus Agalactiae
    Italy

  • Study on the Effectiveness and Safety of Beltavac for Patients with Allergic Rhinitis from House Dust Mites

    Recruiting

    3 1
    Investigated Diseases:
    • Mite allergy
    Investigated Drugs:
    • Mixture Of Allergen Extracts Of Dermatophagoides Pteronyssinus And Dermatophagoides Farinae Polymerized With Glutaraldehyde
    Spain

  • Study on [68Ga]FAPI-46 to Detect Fibroblast Activity in Patients with Non-Resolving Acute Respiratory Distress Syndrome (ARDS) in the ICU

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute respiratory distress syndrome
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    The Netherlands
Previous Page
1 … 616 617 618 619 620 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!